Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study

• Published in: The American journal of clinical nutrition Vol. 77; no. 5; pp. 1318 - 1323
• Main Authors: Oort, Floor V.A. van, Melse-Boonstra, Alida, Brouwer, Ingeborg A, Clarke, Robert, West, Clive E, Katan, Martijn B, Verhoef, Petra
• Format: Journal Article
• Language: English
• Published: Bethesda, MD American Society for Clinical Nutrition 01.05.2003
• Subjects: administration & dosage; adults; Aged; Biological and medical sciences; blood; Dietary Supplements; disease; dose response; Dose-Response Relationship, Drug; Double-Blind Method; Feeding. Feeding behavior; Female; folic acid; Folic Acid - administration & dosage; Folic Acid - blood; Folic Acid - pharmacology; fortification; Fundamental and applied biological sciences. Psychology; homocysteine; Homocysteine - blood; Humans; Male; men; Middle Aged; pharmacology; Regression Analysis; risk; risk factors; serum folate; supplementation; Vertebrates: anatomy and physiology, studies on body, several organs or systems; vitamin-b-6; women; Human; homocysteine; Thiol; adult population; Supplemented diet; Folic acid; dose-response curve; Feeding; Blood plasma; Dose activity relation; Sulfur containing aminoacid; Homocystein; dose response; food fortification; Adult; Macronutrient; Dose; Elderly; Quantitative analysis
• ISSN: 0002-9165; 1938-3207
• DOI: 10.1093/ajcn/77.5.1318

Background: Elevated homocysteine concentrations, a likely risk factor for cardiovascular disease, can be lowered effectively with folic acid. The minimum dose of folic acid required for maximal reduction of homocysteine concentrations is not yet known reliably. Objective: We aimed to determine the lowest folic acid dose that decreases plasma homocysteine concentrations adequately in healthy older adults. Design: A dose-response trial with a randomized, double-blind, parallel-group, placebo-controlled design was carried out among 316 Dutch men and women aged 50–75 y. Subjects received daily for 12 wk either a placebo or 1 of the 6 following folic acid doses: 50, 100, 200, 400, 600, or 800 μg. The relative changes in plasma homocysteine concentration in response to increasing doses of folic acid were used to calculate the dose-response curve. An adequate dose of folic acid was defined as the dose that induced ≥ 90% of the maximal reduction in homocysteine concentration. Results: The relative decrease in plasma homocysteine concentration was associated exponentially with increasing doses of folic acid. From the dose-response curve, the adequate daily dose of folic acid was estimated to be 392 μg, which decreased plasma homocysteine concentrations 22%. Conclusion: In older adults, daily supplementation with folic acid effectively lowers plasma homocysteine concentrations, and a daily dose of ≈400 μg is the minimum dose required for adequate homocysteine reduction.